FONAR Corporation (FONR)
FONAR Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
FONAR Corporation (FONR) is a Medical - Devices company based in US with a market capitalization of $117.6M. Revenue grew 1.4% year-over-year and the company generated $7.4M in free cash flow. This page tracks FONR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 520 employees · IPO Oct 29, 1981
Valuation
Valuation & price
$18.86 · as of May 17, 2026 · -1.3% vs 52w high
14.8
P/E ratio
Latest-FY diluted EPS
0.68
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$117.6M
Market cap
1.4%
Revenue growth (YoY)
41.1%
Gross margin
$7.4M
Free cash flow (USD)
-$17.5M
Net debt
Net cash position
-0.5%
Share dilution
4/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is FONAR Corporation's market cap?
FONAR Corporation (FONR) has a market capitalization of $117.6M.
What is FONR's P/E ratio?
FONR trades at a price-to-earnings ratio of 14.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is FONR's price-to-book (P/B) ratio?
FONR trades at 0.68 times book value per share.
Are insiders buying FONR stock?
SEC Form 4 filings show no open-market insider buys at FONAR Corporation in the last 90 days (0 sells).
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.